MedTrace Logo

Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine Olfaction

NCT00757952 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2016-03-30

No results posted yet for this study

Summary

RATIONALE: Studying samples of exhaled breath from patients with ovarian epithelial cancer, polycystic ovarian syndrome, or endometriosis and from healthy participants in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors find and diagnose ovarian epithelial cancer sooner, when it may be easier to treat.

PURPOSE: This clinical trial is studying exhaled breath biomarkers to see how well they find ovarian epithelial cancer in patients with newly diagnosed ovarian epithelial cancer, polycystic ovarian syndrome, or endometriosis and in healthy participants.

Conditions

Interventions

OTHER

Fourier transform ion cyclotron resonance mass spectrometry

OTHER

chromatography

OTHER

diagnostic laboratory biomarker analysis

OTHER

questionnaire administration

Sponsors & Collaborators

  • Pine Street Foundation

    lead OTHER

Principal Investigators

  • Michael McCulloch, MPH, PhD · Pine Street Foundation

Eligibility

Min Age
21 Years
Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00757952 on ClinicalTrials.gov